Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 55 min ago
Peer-reviewedLicence not statedNew England Journal of Medicine

Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials

  • Yves A Dauvilliers1,2,3
  • Emmanuel Jean-Marie Mignot4
  • Jakub Antczak5
  • Isabelle Arnulf6
  • Lucie Barateau1,2,3
  • Erik Buntinx7
  • Bruce C Corser8
  • Álex Iranzo9,10,11
  • Ramin Khatami12,13
  • Gert Jan Lammers14,15
  • Katharina Lederer16
  • Kristian Bernhard Nilsen17,18
26 more authors
  • Fabio Pizza19,20
  • Markus Helmut Schmidt21
  • Sheila Sivam22,23,24
  • Oliver Sum‐Ping4
  • 充孝 谷口25
  • 詹淑琴26
  • Anson Abraham27
  • Alice Cai27
  • Yeting Du27
  • Mark R. Etherton27
  • Hélène M. Faessel27
  • Samuel Hsiao27
  • Harisha Kadali27
  • Elena Koundourakis27
  • Melissa Naylor27
  • Rachel Neuwirth27
  • Tina Olsson27
  • Raquel Rogers27
  • Sarah Sheikh27
  • Shinichiro Tanaka27
  • Philipp von Rosenstiel27
  • Christian von Hehn27
  • Yaming Hang27
  • Baiyun Yao27
  • Rafael del Río Villegas28,29
  • Giuseppe Plazzi30,20
30 affiliations
  1. 1Institute for Neurosciences of Montpellier, INSERM, University of Montpellier, Montpellier, France
  2. 2National Reference Network for Narcolepsy, Montpellier, France
  3. 3Sleep–Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalier Universitaire, Montpellier, France
  4. 4Stanford Center for Sleep Sciences and Medicine, Palo Alto, CA
  5. 5Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
  6. 6National Reference Center for Rare Hypersomnias, Pitié-Salpêtrière University Hospital, Assistance Publique–Hôpitaux de Paris, Sorbonne University, Paris
  7. 7ANIMA Research, Alken, Belgium
  8. 8Sleep Management Institute, Cincinnati
  9. 9August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona
  10. 10Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Barcelona
  11. 11Sleep Disorders Center, Neurology Service, Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona
  12. 12Center of Sleep Medicine and Sleep Research, Klinik Barmelweid, Barmelweid, Switzerland
  13. 13Department of Neurology, University Hospital of Bern, Bern, Switzerland
  14. 14Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
  15. 15Stichting Epilepsie Instellingen Nederland, Sleep–Wake Center, Heemstede, the Netherlands
  16. 16Advanced Sleep Research, Berlin
  17. 17Department of Neurology, Section for Clinical Neurophysiology, Clinic for Neuroscience, Oslo University Hospital, Oslo
  18. 18Institute of Clinical Medicine, University of Oslo, Oslo
  19. 19Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
  20. 20IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
  21. 21Sleep–Wake–Epilepsy Center, Department of Neurology, Bern University Hospital, Bern, Switzerland
  22. 22Royal Prince Alfred Hospital, Sydney
  23. 23University of Sydney, Sydney
  24. 24Woolcock Institute of Medical Research, Sydney
  25. 25Sleep Medical Center, Osaka Kaisei Hospital, Osaka, Japan
  26. 26Department of Neurology, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing
  27. 27Takeda Development Center Americas, Cambridge, MA
  28. 28Department of Clinical Medical Sciences, Universidad CEU (Centro de Estudios Universitarios) San Pablo, CEU Universities, Madrid
  29. 29Neurophysiology and Sleep Disorders Unit, Vithas Hospitals, Madrid
  30. 30Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
Open at sourceDOICite

Related

  1. Psychometric properties of the novel patient-reported Functional Impacts of Narcolepsy Instrument (FINI) using data from phase 3 clinical trials in narcolepsy type 1
    Heather Romero, Yulia Savva, Stephen Crawford +3
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeuroscienceCrossrefEurope PMCEurope PMCPMC
  2. The effectiveness and value of oveporexton for narcolepsy
    Dmitriy Nikitin, Grace A. Lin, Sol Sanchez +4
    Journal of Managed Care & Specialty PharmacyPeer-reviewedLicence not statedFull textNeurosciencePMC
  3. Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials.
    Iain B McInnes, Linda Stein Gold, Robert Bissonnette +11
    Journal of psoriasis and psoriatic arthritisPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Abnormal brain functional network dynamics in narcolepsy type 1 patients
    F. Xiao, M. Wang, W. Wang +4
    Sleep MedicinePeer-reviewedLicence not statedNeuroscienceHAL
  5. Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model
    Francois Ricordeau, Sebastien Arthaud, Leila Langbour +6
    Annals of NeurologyPeer-reviewedCC BYFull textNeuroscienceEpidemiology & public healthHAL

Cite

BibTeXRIS
BibTeX
@article{dauvilliers2026oveporexton,
  title = {{Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials}},
  author = {Yves A Dauvilliers and Emmanuel Jean-Marie Mignot and Jakub Antczak and Isabelle Arnulf and Lucie Barateau and Erik Buntinx and Bruce C Corser and Álex Iranzo and Ramin Khatami and Gert Jan Lammers and Katharina Lederer and Kristian Bernhard Nilsen and Fabio Pizza and Markus Helmut Schmidt and Sheila Sivam and Oliver Sum‐Ping and 充孝 谷口 and 詹淑琴 and Anson Abraham and Alice Cai and Yeting Du and Mark R. Etherton and Hélène M. Faessel and Samuel Hsiao and Harisha Kadali and Elena Koundourakis and Melissa Naylor and Rachel Neuwirth and Tina Olsson and Raquel Rogers and Sarah Sheikh and Shinichiro Tanaka and Philipp von Rosenstiel and Christian von Hehn and Yaming Hang and Baiyun Yao and Rafael del Río Villegas and Giuseppe Plazzi},
  journal = {New England Journal of Medicine},
  year = {2026},
  month = sep,
  doi = {10.1056/nejmoa2601598},
  url = {https://ruj.uj.edu.pl/handle/item/585508},
}
RIS
TY  - JOUR
TI  - Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
AU  - Yves A Dauvilliers
AU  - Emmanuel Jean-Marie Mignot
AU  - Jakub Antczak
AU  - Isabelle Arnulf
AU  - Lucie Barateau
AU  - Erik Buntinx
AU  - Bruce C Corser
AU  - Álex Iranzo
AU  - Ramin Khatami
AU  - Gert Jan Lammers
AU  - Katharina Lederer
AU  - Kristian Bernhard Nilsen
AU  - Fabio Pizza
AU  - Markus Helmut Schmidt
AU  - Sheila Sivam
AU  - Oliver Sum‐Ping
AU  - 充孝 谷口
AU  - 詹淑琴
AU  - Anson Abraham
AU  - Alice Cai
AU  - Yeting Du
AU  - Mark R. Etherton
AU  - Hélène M. Faessel
AU  - Samuel Hsiao
AU  - Harisha Kadali
AU  - Elena Koundourakis
AU  - Melissa Naylor
AU  - Rachel Neuwirth
AU  - Tina Olsson
AU  - Raquel Rogers
AU  - Sarah Sheikh
AU  - Shinichiro Tanaka
AU  - Philipp von Rosenstiel
AU  - Christian von Hehn
AU  - Yaming Hang
AU  - Baiyun Yao
AU  - Rafael del Río Villegas
AU  - Giuseppe Plazzi
PY  - 2026
DA  - 2026/09/09
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2601598
UR  - https://ruj.uj.edu.pl/handle/item/585508
SN  - 0028-4793
SN  - 0096-6762
SN  - 1533-4406
SN  - 2331-4710
ER  -